In July 2026, cutting-edge achievements in China's heavy ion therapy sparked widespread discussion at the BMIT-GRN International Academic Symposium. Wuwei Cancer Hospital showcased its first independently developed heavy ion system and AI-enabled innovative projects, covering over a hundred types of tumors with efficacy surpassing international standards, thereby promoting deep integration of industry, academia, and research as well as enhanced international collaboration.

Leading Experts Convene in Wuwei to Chart New Course for Precision Radiotherapy in Lung Cancer

Gansu Province Wuwei Tumor Hospital has achieved a breakthrough in heavy ion fusion nuclear medicine therapy for tumors, hosting the nation's first and second heavy ion systems. It has launched alpha/beta radionuclide-targeted therapies to overcome challenges such as liver and pancreatic cancers, led the formulation of national diagnostic and treatment guidelines, and is guiding China's nuclear medicine sector toward global leadership.

Gansu Tianshui held a promotion meeting for the high-quality integrated development of heavy ion and nuclear medicine technologies. The Gansu Province Wuwei Cancer Hospital, leveraging its dual-center linkage advantages, has cumulatively completed over 3,000 treatments, established a green medical care model, and provided cutting-edge treatment hope for cancer patients.

Professor Kohei Takizawa, a leading Japanese expert, has joined the Gastrointestinal Cancer Center of Wuwei Tumor Hospital in Gansu Province on a regular basis to support the development of its National Key Discipline. Through teaching high-difficulty surgeries, conducting seminars on cutting-edge technologies, and fostering international scientific collaboration, he aims to elevate the diagnosis and treatment standards for digestive system tumors in the Hexi Corridor region, driving the discipline from technical following to standard-setting.

On June 22, the "Silk Road IP Opportunities China" event kicked off at the Lanzhou campus of Gansu Wewei Cancer Hospital. Experience officers and media representatives from multiple countries visited a domestic heavy-ion therapy base, showcasing Gansu's achievements in medical science and innovation. Led by 50 experts, the initiative aims to establish a new highland for heavy-ion treatment and advance health cooperation under the Belt and Road Initiative.

On June 16, the High-Quality Development of Heavy Ion Therapy and Green Medical Care Model Promotion Conference was held in Guiyang. Gansu Province Wuwei Tumor Hospital showcased the breakthrough efficacy of heavy ion therapy in treating refractory tumors such as liver cancer and pancreatic cancer, leveraging its "dual-center" collaborative advantages. By partnering with insurance and aviation services to create a full-chain guarantee system, the hospital aims to make cutting-edge technology accessible to patients worldwide.

On June 14, the High-Quality Development Promotion Conference for Heavy Ion Therapy was held in Kunming. Leveraging the "Bragg Peak" effect, dual centers in Wuwei and Lanzhou have used precision technology to tackle difficult-to-treat cancers such as liver and pancreatic cancer. By innovating a model integrating medical care, insurance, and air transport, they are lighting up new hope for patients' lives.

On June 6, 2026, the "2026 Precision Radiotherapy · Leading the Frontier" conference was held at the Wuwei Heavy Ion Center. Focusing on cutting-edge technologies such as heavy ion therapy and CyberKnife, the event discussed clinical treatment strategies for tumors including lung cancer, while showcasing breakthroughs in domestic heavy ion technology and achievements in an integrated, full-chain diagnostic and therapeutic system.

Adenoid cystic carcinoma of the trachea is difficult to cure? The Wuwei Heavy Ion Center has introduced domestic heavy (carbon) ion technology to precisely target tumors while sparing surrounding healthy tissue. This offers a non-invasive and highly effective new solution for patients with surgical limitations, those unresponsive to conventional radiotherapy, and elderly individuals. With over 2,800 cases treated so far, this approach has significantly improved quality of life and opened a new chapter in airway tumor treatment.